Clinical Trial Update: A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing a novel combination therapy strategy for chronic hepatitis B aiming for functional cure via sustained HBsAg loss, incor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Anti-PD-1 antibody

Snippet

Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Chronic Hepatitis b, Anti-PD-1 Antibody | Phase 2 | Status: RECRUITING